Executive record

John Tattory

Most recent record: TransCode Therapeutics, Inc. names John Tattory interim CFO (named as the incoming officer), effective September 9, 2026. See TransCode Therapeutics, Inc..

1 verified record

2026-09-11 · Interim

TransCode Therapeutics, Inc. names John Tattory interim CFO

This page lists only verified filing records that name John Tattory; it is not a career history. Corrections: the corrections page.